Research Article
Biomedical Potentialities of Silver Nanoparticles for Clinical Multiple Drug-Resistant Acinetobacter baumannii
Table 3
Drug-sensitive results for 38 patients with MDR-AB.
| Drug | Number () | Resistance rate (%) |
| Piperacillin | 38 | 100 | Piperacillin/tazobactam | 38 | 100 | Ampicillin/sulbactam | 34 | 89.5 | Imipenem | 38 | 100 | Meropenem | 38 | 100 | Ceftriaxone | 38 | 100 | Ceftazidime | 38 | 100 | Cefepime | 38 | 100 | Gentamicin | 35 | 92.1 | Tobramycin | 35 | 92.1 | Amikacin | 35 | 92.1 | Ciprofloxacin | 38 | 100 | Levofloxacin | 22 | 57.9 | Trimethoprim/sulfamethoxazole | 18 | 47.4 | Minocycline | 0 | 0 |
|
|